SBL Technologies will be the first major distributor of the Safe Entry Stations, which use artificial intelligence to identify symptoms of infectious disease.

Veterans in risk mitigation, the team at SBL has a long-standing reputation for being at the forefront of innovation in workplace safety, particularly for heavy industrial users.

With a strong presence in Canada and the U.S. and a partnership with Sparta Health, SBL is strongly positioned to permeate the industry with this new offering.

Jonathan Auger, president and founder of JUICEWORKS, commented on the recent announcement.

“SBL is an ideal partner to bring this technology to market. They have a unique perspective on the space, having been immersed in it for many years, and appreciate the value of the solution as a long-term risk mitigation tool,” he remarked.

The Safe Entry Stations use a proprietary AI algorithm developed by Predictmedix, and can now also be configured to screen for impairment by THC and alcohol.

“The market positioning of SBL in workplace health safety and testing technologies provides us with an ideal partner to scale Safe Entry both for infectious disease screening along with impairment screening all over North America and the Caribbean,” said Dr. Rahul Kushwah, COO of Predictmedix.

Completely unique to other solutions on the market, the AI is currently patent pending in North America.

Rich Robillard, managing director of SBL Testing Technologies, called Safe Entry “an incredible screening technology for short and long-term pandemic response/business continuity strategies.”

Predictmedix Inc. is an artificial intelligence company developing disruptive tools for impairment testing and healthcare.

Predictmedix Inc. (PMED) is down 6.06 per cent on the day, trading at $0.31 per share as of 11:07 am ET.